0000950170-24-094845.txt : 20240809
0000950170-24-094845.hdr.sgml : 20240809
20240809164841
ACCESSION NUMBER: 0000950170-24-094845
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240808
FILED AS OF DATE: 20240809
DATE AS OF CHANGE: 20240809
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Miller Deborah Ann
CENTRAL INDEX KEY: 0001868741
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40671
FILM NUMBER: 241193537
MAIL ADDRESS:
STREET 1: C/O NUVALENT, INC.
STREET 2: ONE BROADWAY, 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nuvalent, Inc.
CENTRAL INDEX KEY: 0001861560
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE BROADWAY, 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 508-446-2272
MAIL ADDRESS:
STREET 1: ONE BROADWAY, 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
ownership.xml
4
X0508
4
2024-08-08
0001861560
Nuvalent, Inc.
NUVL
0001868741
Miller Deborah Ann
C/O NUVALENT, INC.
ONE BROADWAY, 14TH FLOOR
CAMBRIDGE
MA
02142
false
true
false
false
Chief Legal Officer
true
Class A Common Stock
2024-08-08
4
M
false
3000
6.89
A
36300
D
Class A Common Stock
2024-08-08
4
S
false
112
65.66
D
36188
D
Class A Common Stock
2024-08-08
4
S
false
624
67.17
D
35564
D
Class A Common Stock
2024-08-08
4
S
false
96
67.95
D
35468
D
Class A Common Stock
2024-08-08
4
S
false
1794
69.34
D
33674
D
Class A Common Stock
2024-08-08
4
S
false
374
69.95
D
33300
D
Stock Option (Right to Buy)
6.89
2024-08-08
4
M
false
3000
0
D
2031-04-29
Class A Common Stock
3000
176608
D
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 27, 2023.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.40 to $66.35, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (6) of this Form 4.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.64 to $67.58, inclusive.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.74 to $68.25, inclusive.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.74 to $69.73, inclusive.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.76 to $70.33, inclusive.
The shares underlying this option vest as follows: 25% of the shares vested on April 15, 2022, and the remainder have vested or shall vest over the three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
/s/ Nathan McConarty, attorney-in-fact
2024-08-09